The ESC Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
At the end of the course delegates will have improved their knowledge in:
Sven Wassmann, MD, PhD, FESCGiuseppe MC Rosano, MD, PhD, FESC
This course is an excellent opportunity for education and networking.
Parallel groups (switch after 60 min):
Examples from recent clinical trials
Registration to the course is open until 30 November 2017.
Fee for Working Group on Cardiovascular Pharmacotherapy members and/or the Austrian Society of Cardiology:
Fee for Cardiovascular Pharmacotherapists and Trialists of Tomorrow:
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903 Sophia Antipolis, FR
Hotel NH Danube City
Wagramer Str. 21
1220 Wien, AT
The course is supported by Pfizer, Amgen and Daiichi Sankyo in the form of educational grants. The scientific programme has not been influenced in any way by its sponsors.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved